Anticholinergic burden quantified using the Japanese risk scale as a predictor of frailty and sarcopenia among community‐dwelling older adults: A 9‐year Kashiwa cohort study
Anticholinergic burden is a predictor of frailty and sarcopenia in community-dwelling older adults. Effective evaluation and management of anticholinergic burden using the Japanese Anticholinergic Drug Risk Scale are crucial for promoting healthy aging and mitigating adverse health outcomes. Geriatr Gerontol Int 2025; 25: 520-527.
Authors
- Taro Kojima (ORCID: https://orcid.org/0000-0003-3857-5267)
- Katsuya Iijima (ORCID: https://orcid.org/0000-0003-1339-5681)
- Bo‐Kyung Son (ORCID: https://orcid.org/0009-0002-2900-6871)
- Tomoki Tanaka (ORCID: https://orcid.org/0000-0002-0977-0998)
- Masahiro Akishita (ORCID: https://orcid.org/0000-0001-5498-7224)
Institutions
- Tokyo Metropolitan Institute of Gerontology (JP)
- Tokyo Metropolitan Geriatric Hospital (JP)
- The University of Tokyo (JP)
- International University of Health and Welfare (JP)
Publication Details
- Journal
- Geriatrics and gerontology international/Geriatrics & gerontology international
- Published
- 2025-03-06
- DOI
- https://doi.org/10.1111/ggi.70012
- Citations
- 2
- Primary Topic
- Frailty in Older Adults
- Type
- article
- Field-Weighted Citation Impact
- 2.45
Funders
- Japan Agency for Medical Research and Development
- Ministry of Health Mexico